Establishment Labs director receives 286-share stock grant

Slotkin Bryan reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Slotkin Bryan reported acquisition or exercise transactions in this Form 4 filing.

Establishment Labs Holdings Inc. director Bryan Slotkin received an automatic grant of 286 common shares valued at $56.78 per share. These shares were taken in lieu of his quarterly cash retainer under the company’s Outside Director Compensation Policy and issued from the 2018 Equity Incentive Plan.

Following this award, Slotkin directly holds 30,256 common shares. This is a routine, compensation-related equity grant rather than an open‑market share purchase.

Insider Trade Summary

Grant/Award: 286 shares

Grant/Award 1 txn

Insider Slotkin Bryan

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	286	$56.78	$16K

Holdings After Transaction: Common Shares — 30,256 shares (Direct)

Footnotes (1)

1. F1. Represents common shares elected to be received in lieu of a quarterly cash retainer payment in accordance with the Reporting Person's prior election under the Issuer's Outside Director Compensation Policy. The common shares were issued pursuant to the Issuer's 2018 Equity Incentive Plan and determined based on the closing price of the Issuer's common shares on the last trading day of the quarter.

Key Figures

Share grant: 286 shares Grant price: $56.78 per share Shares held after grant: 30,256 shares

3 metrics

Share grant 286 shares Common shares granted in lieu of quarterly cash retainer

Grant price $56.78 per share Based on closing price on last trading day of the quarter

Shares held after grant 30,256 shares Total direct holdings following the reported transaction

Key Terms

Outside Director Compensation Policy, 2018 Equity Incentive Plan, quarterly cash retainer payment

3 terms

Outside Director Compensation Policy financial

"in accordance with the Reporting Person's prior election under the Issuer's Outside Director Compensation Policy"

2018 Equity Incentive Plan financial

"The common shares were issued pursuant to the Issuer's 2018 Equity Incentive Plan"

quarterly cash retainer payment financial

"common shares elected to be received in lieu of a quarterly cash retainer payment"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ESTA director Bryan Slotkin report in this Form 4 transaction?

Bryan Slotkin reported receiving 286 Establishment Labs common shares as compensation. The shares were granted automatically in place of a quarterly cash retainer, under the company’s Outside Director Compensation Policy and 2018 Equity Incentive Plan at a reference price of $56.78 per share.

Was Bryan Slotkin’s ESTA share transaction a market purchase or a grant?

The transaction was a share grant, not a market purchase. Slotkin elected to receive his quarterly director cash retainer in common shares, which were issued under Establishment Labs’ 2018 Equity Incentive Plan based on the closing share price for the quarter’s last trading day.

How many ESTA shares did Bryan Slotkin receive and at what price?

Bryan Slotkin received 286 Establishment Labs common shares at a reference price of $56.78 per share. The price reflects the closing market price on the last trading day of the quarter, which the company uses to calculate equity issued instead of the cash retainer.

How many ESTA shares does Bryan Slotkin hold after this Form 4 grant?

After this grant, Bryan Slotkin directly holds 30,256 Establishment Labs common shares. This total reflects his position following the award of 286 additional shares elected in lieu of a quarterly cash retainer under the company’s standard outside director compensation program.

Why did ESTA issue shares to Bryan Slotkin instead of paying cash?

Shares were issued because Slotkin previously elected to take his quarterly cash retainer in stock. Under Establishment Labs’ Outside Director Compensation Policy, directors can choose equity instead of cash, with shares calculated using the closing price on the quarter’s final trading day.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/01/2026 - 04:07 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Slotkin Bryan

(Last) (First) (Middle)

C/O MOTIVA USA LLC

16192 COASTAL HIGHWAY

(Street)

LEWES DELAWARE 19958

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ESTABLISHMENT LABS HOLDINGS INC. [ ESTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	03/31/2026		A(1)		286	A	$56.78	30,256	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents common shares elected to be received in lieu of a quarterly cash retainer payment in accordance with the Reporting Person's prior election under the Issuer's Outside Director Compensation Policy. The common shares were issued pursuant to the Issuer's 2018 Equity Incentive Plan and determined based on the closing price of the Issuer's common shares on the last trading day of the quarter.

Remarks:

	/s/ Cassandra "Sandra" Harris	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)